KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Common Equity (2016 - 2026)

CareDx's Common Equity history spans 14 years, with the latest figure at $313.5 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 17.35% to $313.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $313.5 million, a 17.35% decrease, with the full-year FY2025 number at $303.1 million, down 19.91% from a year prior.
  • Common Equity hit $313.5 million in Q1 2026 for CareDx, up from $303.1 million in the prior quarter.
  • Over the last five years, Common Equity for CDNA hit a ceiling of $457.5 million in Q1 2022 and a floor of $256.2 million in Q1 2024.
  • Historically, Common Equity has averaged $356.3 million across 5 years, with a median of $378.4 million in 2024.
  • Biggest five-year swings in Common Equity: tumbled 39.35% in 2023 and later skyrocketed 48.05% in 2025.
  • Tracing CDNA's Common Equity over 5 years: stood at $430.9 million in 2022, then tumbled by 39.35% to $261.3 million in 2023, then skyrocketed by 44.81% to $378.4 million in 2024, then dropped by 19.91% to $303.1 million in 2025, then increased by 3.44% to $313.5 million in 2026.
  • Business Quant data shows Common Equity for CDNA at $313.5 million in Q1 2026, $303.1 million in Q4 2025, and $311.1 million in Q3 2025.